Wang Jiao, Matosevic Sandro
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
Purdue Center for Cancer Research, West Lafayette, IN 47906, USA.
J Clin Med. 2019 Sep 23;8(10):1526. doi: 10.3390/jcm8101526.
CD73, a cell-surface protein encoded by the gene , is overexpressed in glioblastoma (GBM), where it contributes to the tumor's pathophysiology via the generation of immunosuppressive adenosine. Adenosinergic signaling, in turn, drives immunosuppression of natural killer (NK) cells through metabolic and functional reprogramming. The correlation of CD73 with patient survival in relation to GBM pathology and the intratumoral infiltration of NK cells has not been comprehensively studied before. Here, we present an analysis of the prognostic relevance of CD73 in GBM based on transcriptional gene expression from patient data from The Cancer Genome Atlas (TCGA) database. Utilizing bioinformatics data mining tools, we explore the relationship between GBM prognosis, expression, and intratumoral presence of NK cells. Our analysis demonstrates that CD73 is a negative prognostic factor for GBM and that presence of NK cells may associate with improved prognosis. Moreover, the interplay between expression of and specific NK genes hints to potential functional effects of CD73 on NK cell activation.
CD73是一种由该基因编码的细胞表面蛋白,在胶质母细胞瘤(GBM)中过表达,它通过产生免疫抑制性腺苷促进肿瘤的病理生理过程。反过来,腺苷能信号通过代谢和功能重编程驱动自然杀伤(NK)细胞的免疫抑制。此前,尚未全面研究过CD73与GBM病理及NK细胞肿瘤内浸润相关的患者生存率之间的相关性。在此,我们基于来自癌症基因组图谱(TCGA)数据库的患者数据中的转录基因表达,对GBM中CD73的预后相关性进行分析。利用生物信息学数据挖掘工具,我们探究GBM预后、CD73表达与NK细胞肿瘤内存在情况之间的关系。我们的分析表明,CD73是GBM的一个负性预后因素,NK细胞的存在可能与预后改善相关。此外,CD73表达与特定NK基因之间的相互作用提示了CD73对NK细胞激活的潜在功能影响。